Recursion is a Salt Lake City biotech company that uses AI to find and develop medicines for cancer and rare diseases. It last closed at $2.45 on Nov 20, down 9.93% on the day. The next earnings report for RXRX is expected around Wed, Feb 24, 2027. For the quarter ended Sep 2026, RXRX reported EPS of -$0.22 on revenue of $18.6M, with revenue up 258.5% from a year ago. Over its last 8 reports the stock moved an average of 6.0% the session after earnings. Over the last 12 months RXRX insiders bought $0 of stock on the open market and sold $7.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is RXRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RXRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RXRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RXRX · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 43% below its 20 day and 52% below its 50 day average. It is 41% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 31), oversold. The nearest support is the 52 week low at $2.44, and the nearest resistance the Pivot at $2.55.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 13.6%/day
Key levels
$5.2452 week high+113.9%
$3.7250 day average+51.8%
$3.51100 day average+43.3%
$3.5020 day average+42.9%
$3.44200 day average+40.4%
$3.13Swing high (Jul 27)+27.8%
$2.66Pivot R1+8.6%
$2.55Pivot+4.1%
$2.45Last close
$2.4452 week low−0.4%
$2.34Pivot S1−4.5%
Indicators
RSI (14)
31.04
Weak, oversold below 30
Neutral
MACD
-0.31
Below its signal line
Bearish
Stochastic
11.1
Near the bottom of its range
Oversold
ADX (14)
24.6
Weak trend
Williams %R
-99.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-155.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−30.4%
Change over 10 sessions
Bearish
ATR (14)
$0.33
Typical daily range, 13.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 26.2%/day
Key levels
$5.2452 week high+113.9%
$3.7250 day average+51.8%
$3.51100 day average+43.3%
$3.5020 day average+42.9%
$3.44200 day average+40.4%
$3.13Swing high (Jul 27)+27.8%
$2.66Pivot R1+8.6%
$2.55Pivot+4.1%
$2.45Last close
$2.4452 week low−0.4%
$2.34Pivot S1−4.5%
Indicators
RSI (14)
38.50
Weak, oversold below 30
Neutral
MACD
-0.08
Below its signal line
Bearish
Stochastic
12.8
Near the bottom of its range
Oversold
ADX (14)
16.3
No clear trend
Williams %R
-99.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-164.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−23.4%
Change over 10 sessions
Bearish
ATR (14)
$0.64
Typical daily range, 26.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for RXRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RXRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow RXRX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RXRXHow many large options trades hit RXRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RXRX in the last 90 days.
From SEC Form 4 filings by RXRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RXRX is in one of them and how their past RXRX trades turned out.
Recursion is a biotechnology company based in Salt Lake City, Utah, that uses artificial intelligence to discover and develop medicines. Its work centers on the Recursion Operating System, a platform that combines biological data, computational molecule design and clinical trial planning. The company develops its own drug candidates, mainly for cancer and rare diseases, and partners with drugmakers such as Roche, Genentech and Sanofi on discovery programs. Its medicines are aimed at patients with serious diseases that have limited treatment options.